Perhaps the most important factor to limit the effectiveness of vaccines against virus infections is that of virus variation. Successful vaccines have been developed against viruses such as those causing smallpox, measles, yellow fever and poliomyelitis, and they are effective against most circulating virus strains. However, with some viruses vaccination has been much less successful either because numerous antigenically distinct strains co-circulate, as is the case for rhinoviruses, or because new strains are continually emerging, as in the case of influenza virus. Despite the importance of virus variability, little is known about the factors that influence it and that are responsible for the dramatically different patterns of variation displayed by different viruses. The primary source of variation is obviously mutation, and it has been suggested in several recent papers that the extreme variability of some viruses may be a consequence of an unusually high rate of mutation Reanney, 1984; Domingo et al., 1985 ; Saitou & Nei, 1986) . The purpose of this analytical review is to summarize recent information about the mutation rates of eukaryotic viruses, and to discuss the relationship between such rates and virus variability in the field.
Measurement of virus mutation rates Direct methods
The mutation rate of a virus can be defined as the probability that during a single replication of the virus genome a particular nucleotide position is altered through substitution, deletion, insertion or recombination. Many different techniques have been used to measure virus mutation rates and these vary in their accuracy and in the extent to which they have been applied to different viruses. One of the most direct techniques is to measure the error rate in vitro of the polymerase that is responsible for replication of the virus genome. An error rate of between t 0-2.4 and 10 -2"8 can be estimated for the reverse transcriptase encoded by retroviruses, based on the frequency of nucleotide misincorporation during transcription in vitro of homopolymers of ribo-or deoxyribonucleotides (for review, see Loeb & Kunkel, 1982) [where necessary, polymerase error rates and nucleotide substitution frequencies have been recalculated from the published data so that they represent the frequency at which a given nucleotide at a particular position in a virus genome is replaced by any of the other three nucleotides]. This high error rate is partly due to the artificial nature of the template since lower error rates (10 -31 to 10 -4"5) are observed during the replication of alternating copolymers of deoxyribonucleotides (Battula & Loeb, 1974) or of DNA from a mutant bacteriophage. In this last instance, the error rate is inferred from the increased reversion frequency of the mutant following replication in vitro after taking into account the number of mutations capable of producing a revertant and the penetrance of revertants (0.39) (references in Loeb & Kunkel, 1982) . Using a different technique, the error rate of the vesicular stomatitis virus (VSV) RNA polymerase has been estimated to be 10 3-15 (Steinhauer & Holland, 1986) . The error rate at a particular guanosine residue in in vitro transcripts of VSV defective interfering particle RNA was deduced from the proportion of transcripts that were no longer susceptible to cleavage at this site by ribonuclease T1, a nuclease that cleaves specifically at guanosine residues. If the template RNA were completely homogeneous, then this proportion would be equal to the polymerase error rate. In fact, the VSV RNA that was used as a template contained nucleotide substitutions at a frequency (10 -35) similar to that observed in the transcripts (Steinhauer & Holland, 1986) , and so it is possible to place 10 -3'15 as only an upper limit of the error rate.
While it would be of interest to see these techniques applied to other viruses, it should also be noted that the error rate of a potymerase in vivo may be much lower than that measured in vitro using purified polymerase on a foreign template. Furthermore, an RNA template suitable for replication by RNA polymerases must either be a homopolymer and hence an unnatural template, or else be a complex polynucleotide synthesized by an RNA polymerase. Because RNA polymerases are not known to possess the efficient error-correction mechanisms displayed by prokaryotic and eukaryotic DNA polymerases (reviewed by Loeb & Kunkel, 1982) , any complex RNA molecule will contain nucleotide substitutions at a level that may obscure any further errors introduced during replication by a virus RNA polymerase. Finally, if several different polymerases are involved in the replication of a virus genome, as is the case for retroviruses, the contribution of each of these polymerases to the overall mutation rate needs to be assessed.
Virus mutation rates can also be estimated from the frequency of nucleotide substitution in the genomes of a population of virus derived from a single purified clone. Such estimates may not accurately reflect virus mutation rates since some mutant genomes will be inviable and since the number of replicative events involved in the production of a virus population may be uncertain. Despite these considerations, it is clear that the analysis of nucleotide substitution frequencies in virus genomes will yield useful information about the relative variability of different viruses. As described above, a substitution frequency of 10 -3.5 has been observed at a particular guanosine residue in VSV defective interfering particle RNA, and similar frequencies have been measured for coding and non-coding regions of the VSV genome (Steinhauer & Holland, 1986; D. Steinhauer, personal communication) .
Nucleotide substitution frequencies can also be measured by direct nucleotide sequence analysis of numerous virus clones each derived from the same plaque; a frequency of 10 -4"1 has been observed in the influenza virus NS segment, and a significantly lower frequency of < 10 -5.o for the poliovirus type 1 VP 1 gene (Parvin et al., 1986) . Although quantification is difficult, both the influenza virus NS segment and the poliovirus VP1 gene are capable of variation and so this difference in substitution frequency may reflect a difference in mutation rates of the two viruses. The extension of this approach to other viruses would be of considerable interest, but is likely to be hindered by the heroic scale of the work required [over 180000 nucleotides were sequenced in order to observe seven substitutions in the work of Parvin et al. (1986) ]. For RNA viruses such sequence analysis can not be of cloned cDNA since copying of RNA by reverse transcriptase probably introduces errors at a rate of between 10 -3 and 10 -4 (see above). Thus, while substitution frequencies of 10 -3.6 and 10 -3 have been observed in cDNA clones of influenza virus and VSV RNA (Fields & Winter, 1981 ; Schubert et al., 1984) , most of the alterations may have been introduced during reverse transcription of the virus RNA. Other techniques for the analysis of virus genomes such as oligonucleotide fingerprinting of RNA or digestion of DNA with restriction enzymes have been used to monitor the emergence of virus variants following multiple passages (Brand & Palese, 1980; Coffin et al., 1980; Spindler et al., 1982; Sobrino et aL, 1983; Hahn et al., 1986) but are too insensitive to detect the rare differences between clones of a single virus.
Indirect methods
Instead of measuring substitution frequencies through direct analysis of virus genomes, it is possible to estimate them from the frequency of variants displaying a particular phenotype in a cloned virus stock. Phenotypes that can be influenced by many different mutations in several genes, such as temperature-sensitive (ts) growth, plaque morphology, host range and pathogenicity, will clearly be of little use for this type of analysis. On the other hand, the reversion frequency of variants altered in one of these phenotypes could be used to measure substitution frequencies if the precise nature of the mutations in the variant and in its revertants were known. Unfortunately, for several reasons, these criteria are rather difficult to meet. First, variants will often contain multiple mutations, sometimes because they are derived from mutagenized stocks or have complex passage histories, but also because there is selection by virologists for variants with a phenotype that is clearly distinct from that of the wild-type virus, and such variants may only be isolated after several rounds of selection. For instance, ts mutants that are totally incapable of growth at the non-permissive temperature are good candidates for biochemical characterization, but are likely to contain several different lesions. Thus four different ts mutants of influenza virus were each found to bear three or more mutations in the neuraminidase gene alone (Bos & Nayak, 1986) , four ts mutants of VSV each contained between two and four lesions in the M gene (Morita et al., 1987) and there are frequent reports of ts mutants that carry ts lesions in more than one virus gene. Hence, in order to interpret the reversion frequency of a variant virus, all of the mutations responsible for the altered phenotype of the variant must be located and accounted for in any revertants. A second difficulty in interpreting the reversion frequency of variant viruses is the occurrence of pseudo-reversion, a situation in which lesions of the variant virus are still present in a revertant, but their phenotypic effects are suppressed by additional mutations. Suppressor mutations are common among revertants of influenza virus and VSV ts mutants (Scholtissek & Spring, 1981; Morita et al., 1987) and are responsible for about 90~ of the revertants of reovirus ts mutants (Joklik, 1985) . Finally, the nucleotide substitution frequency of a variant virus might be quite different from that of the wild-type virus if the variant contains lesions in its polymerase genes. For example, a mutant of herpes simplex virus (HSV) with a lesion in the DNA polymerase gene gives rise to thymidine kinase mutants at a frequency between 10 and 100 times lower than that of wild-type virus (Hall et al., 1984) , while a ts mutation in the L (polymerase) gene of VSV apparently produces an increased rate of mutation in other virus genes (Pringle et al., 1981) .
Together, these considerations imply that detailed characterization of variant viruses and their revertants is necessary before reversion frequencies can be equated with the frequency of nucleotide substitution in the virus genome. Some studies have come close to these requirements: substitution frequencies can be estimated to be < 10 -6.8 for a host range mutant of Sindbis virus (Durbin & Stollar, 1986) , 10 -3.2 and 10 -3.5 for two ts mutants of influenza virus (Sugiura et al., 1972; Bos & Nayak, 1986 ) and 10 -3"5, 10 -3"6, 10 -4"° and 10 -4.9 for four ts mutants of VSV (Morita et al., 1987) , while nonsense mutants of HSV or simian virus 40 (SV40) revert to wild-type at a frequency of 10 -4 (Campione-Piccardo et al., 1979) or 10 -5 (Rawlins et al., 1983) implying nucleotide substitution at frequencies of > 10 -4.4 and > 10 -5.4 respectively.
A less problematic approach to the measurement of nucleotide substitution frequencies is to observe the frequency of variants in a cloned population of wild-type virus that are resistant to inhibitors of virus replication. The location of mutations capable of conferring resistance can be discovered through nucleotide sequence analysis and this information can then be used to calculate the substitution frequency. For example, mutants of poliovirus that are resistant to guanidine occur at a frequency of between 10 -6"7 and 10 -7'4 and a resistant phenotype is found to require two independent mutations (Pincus et al., 1986) , implying a nucleotide substitution frequency of between 10 -3.o and 10 -3"4. Unfortunately, many antiviral drugs are excluded from this type of analysis because they do not completely inhibit the replication of wild-type virus, and the multiple rounds of selection required for the selection of variants preclude the calculation of variant frequencies.
Another way of estimating nucleotide substitution frequencies, for which there are abundant data, is to measure the frequency of variants in cloned virus stocks that are resistant to neutralization by monoclonal antibodies (Table 1 ). The frequency of neutralization-resistant variants is not constant for a particular virus, but can range over more than two orders of magnitude depending on the monoclonal antibody used for selection. One reason for this might be that no account has been taken of the number of mutations that are required for, or capable of producing, a resistant phenotype. Those instances where the variant frequency is very low (< 10 -6"8) may indicate that two or more independent mutations are required. For some monoclonal antibodies the mutations present in resistant variants have been localized by nucleotide sequence analysis and so the nucleotide substitution frequency can be calculated as three times the frequency of variants divided by the number of different mutations that can 
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produce a neutralization-resistant phenoptype (Table 2) . In general, the number of potential mutations does not correlate with the frequency of variants and so the nucleotide substitution frequencies calculated for a particular virus using different monoclonal antibodies vary quite considerably. These substitution frequencies may often be over-estimated if only a few variants have been characterized since there may be additional mutations that can lead to a resistant phenotype. For example, a detailed study has been made of variants of human rhinovirus type 14 that are resistant to neutralization by a large panel of monoclonal antibodies; in this case a correlation was observed between the variant frequency and the number of mutations that are capable of endowing resistance to neutralization (Sherry et al., 1986 ; B. Sherry, personal communication) (Table 2 ). Another factor that hinders the exact calculation of nucleotide substitution frequencies is that monoclonal antibodies may differ in their ability to neutralize mosaic virions that contain a mutant genome but possess both mutant and wild-type forms of the target antigen (Sherry & Rueckert, 1985) . Care must therefore be taken that variants are selected from pools of virus that have been prepared after infection at a low multiplicity. In addition, the concentration of antibody used during the selection of neutralization-resistant variants can affect the variant frequency by several orders of magnitude (Lazdins et al., 1985) , and so selection should be performed under optimal conditions. In some cases a virus antigen may be a target for a neutralizing monoclonal antibody but may not be essential for virus replication, and so variants carrying deletions of all or part of the virus antigen will contribute to the pool of neutralization-resistant variants. Such variants of HSV have been isolated following selection with monoclonal antibodies that recognize glycoprotein C (gC) (Holland et al., 1984; Marlin et al., 1985) . Whichever method is used to measure virus mutation rates it should be noted that different regions of a virus genome may have very different mutation rates because of effects of secondary structure on the fidelity of replication (Weddell et al., 1985) . The mutation rate may also depend on whether a transition or transversion mutation is required for the variant phenotype. Transversions occur about six times less frequently than would be expected by chance when the nucleotide sequences of influenza virus genes from different isolates are compared (Both et al., 1983; Martinez et al., 1983; Ortin et al., 1983) even when only silent mutations are considered (Verhoeyen et al., 1980) . Different isolates of the same virus may even have different mutation rates if they encode altered forms of the virus polymerase (Pringle et al., 1981 ; Hall et al., 1984) . Furthermore, sources of mutation other than nucleotide misincorporation, such as deletion, insertion, duplication and inversion, will each occur at a particular frequency, although there is little information about what these frequencies might be. Insertion of a single cytosine nucleotide into a stretch of eight cytosine residues in the genome of polyoma virus occurs at a frequency of 10 -5.6 (Wilson et al., 1986) while deletions that inactivate the HSV gC gene occur at a frequency of 10 -3.7 (Holland et al., 1984; Marlin et al., 1985) . Both deletion and insertion are involved in the generation of antigenic diversity as evidenced by nucleotide sequence analysis of different field isolates of influenza virus (Verhoeyen et al., 1983; Buonagurio et al., 1985) and acquired immune deficiency syndrome virus (Hahn et al., 1986) .
Comparison of the mutation rates of different viruses
Although, as has been emphasized in this review, there are many difficulties involved in the measurement of virus mutation rates, it is of interest to see whether any trends emerge from the data that are available. First, it should be noted that different methods of measuring virus mutation rates can sometimes give very different results. For example the substitution frequency in influenza virus RNA is estimated at about 10 -6 from the frequency of defined variants resistant to neutralization by monoclonal antibodies (Table 2 ) whereas frequencies 100-fold higher are indicated by the reversion frequency of ts mutants (Suguira et al., 1972; Bos & Nayak, 1986) or by direct sequencing of RNA from related clones (Parvin et al., 1986) . Similarly, the frequency of neutralization-resistant variants of VSV (Table 1) is 10-to 100-fold lower than would be predicted from the reversion frequency of VSV ts mutants (10 -3.5 to 10 -'*'9) (Morita et al., 1987) or from direct measurement of the frequency of nucleotide substitution in VSV genomic RNA (10 -3"7) (Steinhauer & Holland, 1986 ). In contrast, direct sequencing of RNA from clones of poliovirus (Parvin et al., 1986) yields an estimated substitution frequency (< 10 -5"°) that is 10-to 100-fold lower than that suggested by the frequency of guanidineresistant mutants (Pincus et al., 1986) or of neutralization-resistant variants (Table 2) .
Although there is no simple explanation for these differences, there are several sources of inaccuracy associated with indirect measurements of substitution frequencies (discussed above) and so, ideally, comparisons between viruses would be based on direct measurements of the mutation rate. At present, however, such information is limited to four estimates, each for a different virus, and made using three different methods (Loeb & Kunkel, 1982; Parvin et al., 1986; Steinhauer & Holland, 1986) . Until these methods are applied more generally, a comparison of the mutation rates of different viruses can only be based on more indirect measurements, and in particular on the abundant data concerning the frequency and structure of variants resistant t O neutralization by monoclonal antibodies (Tables 1, 2) . Indeed, these data may be most appropriate to use when assessing the relationship between the field variation of a virus and the rate at which new variants are produced, since whatever biases occur during the selection of neutralization-resistant variants may also occur during natural infections.
The frequency of neutralization-resistant variants has a typical value for each virus (Table 1 ) which is similar to the estimated frequency of nucleotide substitution for that virus ( Table 2) . Frequencies of about 10 -6 are typical for influenza virus, parainfluenza virus and coronavirus, slightly higher frequencies (10-5) are observed for rhinovirus and even higher frequencies (10 -4) for poliovirus, rabies virus and rotavirus. Information concerning the mutation rate of DNA Viruses is sparse, but such data as there are suggest that these rates may be quite similar to those of RNA viruses. Neutralization-resistant variants occur at a frequency of 10 -5 or greater for HSV (Tables 1,2 ) and at a frequency of between 10 -3s and 10 -5.`* for canine parvovirus (Parrish & Carmichael, 1983) , while the reversion frequency of nonsense mutants of HSV or SV40 suggests nucleotide substitution frequencies of > 10 -4.4 and > 10 -s'4 respectively (CampionePiccardo et al., 1979; Rawlins et al., 1983) . These frequencies are well within the range observed for RNA viruses, and contrast with the suggestion of several recent articles that the mutation rate of RNA viruses is uniquely high Reanney, 1984; Schubert et al., 1984; Domingo et al., 1985) . The rationale for this suggestion was that while error-correction mechanisms are well documented for both cellular and virus-specific DNA polymerases of prokaryotes as well as the DNA polymerases of eukaryotic cells (Loeb & Kunkel, 1982) , such mechanisms had not been described for any RNA polymerase. In fact recent evidence suggests that an error-correction mechanism may be associated with the influenza virus RNA polymerase (Ishihama et al., 1986) and still very little is known about proof-reading by DNA polymerases encoded by eukaroyotic viruses; a 3' ~ 5' exonuclease activity co-purifies with the HSV DNA polymerase (Derse & Cheng, 1981) , and an anti-mutator variant of HSV has been described (Hall et al., 1984) . Surprisingly, high substitution frequencies are observed even for viruses such as SV40 and parvovirus whose genome is replicated by cellular DNA polymerases with error rates of < 10 -8 (Drake, 1969; Mukai & Cockerham, 1977; Vogel & Motulsky, 1982) . Hence, it appears that both RNA and DNA viruses of eukaryotes may have mutation rates that are much higher than those of their hosts.
Lack of correlation between virus mutation rates and rates of field variation
Before discussing the relationship between virus mutation rates and the extent of virus variation in the field, it is first necessary to distinguish two different types of field variation. One type is the variation between different strains of a virus that co-circulate at any one time. This type of variation will not be greatly affected by the virus mutation rate since, except for newly § (a) Evans et al. (1983); Minor et al. (1983) . (b) Emini et al. (1983); Diamond et al. (1985) . (c) Blondel et al. (1986) . (d) Self et al. (1985) . (e) Gerhard et al. (i981); Caton et al. (1982) . (f) Webster et al. (1982); Lentz et al. (1984) . (g) Kousoulas et al. (1984); Pellett et al. (1985) . (h) Coelingh et al. (1985 Coelingh et al. ( , 1986 . ( 11 There are three non-silent mutations in the variant sequence, some or all of which may be required for resistance to neutralization. evolved host-virus relationships, the level of virus variation should reach equilibrium. In contrast, the other type of field variability, that of variation between strains isolated at different times, might be affected by the virus mutation rate.
Extensive data on the rate of annual variation are available from nucleotide sequence analysis of influenza virus. Nucleotide substitutions in the haemagglutinin and neuraminidase genes of influenza virus are estimated to occur at a rate of 0.4 to 0.7~ of nucleotides per year (Both et al., 1983; Martinez et al., 1983; Raymond et al., 1983; Saitou & Nei, 1986) and at a rate of about 0.2~ in the matrix and non-structural genes Buonagurio et al., 1986b) . Differing functional constraints are probably responsible for differences between genes in the rate of variation since the rate of functionally silent nucleotide substitutions is quite similar for all influenza virus genes (0-6 to 1-4 ~ per nucleotide per year) while non-silent substitutions occur at a lower and more variable rate (0.03 to 0.3~) (Hayashida et al., 1985) . High rates of nucleotide substitution (0"18 to 0"2~o) have also been observed for the haemagglutinin gene of influenza B virus (Krystal et al., 1983; Verhoeyen et al., 1983) and can be contrasted with the rate of evolution of mammalian genes in the absence of selection, which is between 10 -81 and 10 -9 per nucleotide per year (Li et al., 1981 ; Li & Tanimura, 1987) . In contrast, annual rates of variation cannot be calculated for isolates of influenza C virus because, unlike influenza A and B viruses, sequential isolates do not form a simple lineage (Buonagurio et al., 1985 (Buonagurio et al., , 1986a ). This dramatic difference occurs despite the similar replication strategies and presumably mutation rates of influenza A, B and C viruses.
Annual rates of variation have also been measured for strains of poliovirus isolated during an epidemic in an unvaccinated community. Oligonucleotide mapping suggested annual rates of nucleotide substitution of approximately 1 or 2~ , and indeed similar rates of change have been observed following the passage of virus through one or two individuals . By use of the same techniques, the rate of variation in the genome of enterovirus type 70 has been estimated to have averaged 0.43 ~ per nucleotide per year over the course of 10 years (Takeda et al., 1984) . These rates of change are quite similar to those estimated for influenza A and B viruses although the substitution frequency of influenza virus is apparently about 100 times lower than that of picornaviruses as estimated from the frequency of neutralization-resistant variants (Tables 1, 2) .
A substitution rate of 10 -8.3 per year has been estimated for papovaviruses based on nucleotide sequence comparison of viruses isolated from different mammalian species (Soeda & Maruyama, 1982) but the assumption that divergence of these viruses began at the same time as that of their hosts may well be invalid. Unfortunately, rates of annual change are not available for other viruses, sometimes because the virus is perceived as being stable and no attempt has been made to analyse sequential isolates or because the virus exists as so many different serotypes that it becomes difficult to trace the evolution of a particular lineage (Sobrino et al., 1986) . Information is obviously limited, but the examples cited give no indication that the mutation rate of a virus determines its rate of field variation.
Other factors afJecting the rate oj~ield variation of viruses
Instead, it may be that all viruses have relatively high mutation rates and the rate of field variation of a virus may actually be determined by other factors that alter the intensity of selection. For example, while some viruses are accessible to immune attack throughout infection, other viruses such as HSV replicate in a site that is protected from immune attack and so only encounter antigenic selection when they infect a previously infected individual. The intensity of selection will also be relatively low for viruses that are uncommon in the population since re-infection of individuals will be rare (Verhoeyen et al., 1983) . In contrast, a potential source of intense selection is that of the 'founder effect' which occurs if infection is initiated by a very small number of virus particles (Brand & Palese, 1980; Domingo et al., 1980; Buonagurio et al., 1985) or if successful variants are extremely rare. The rapidity with which the host mounts an immune response and the effectiveness of this response will influence the intensity of infection (Palese & Young, 1982; Buonagurio et al., 1985) , although in a complex fashion since these factors will also affect the size of the virus population that is subject to selection.
The rate of field variation of a virus may also depend on the inherent properties of those virus antigens which are targets of immune attack. For example, if an antigen is the target for a neutralizing antibody response but is unable to accept structural alterations that could prevent it from being recognized by such antibodies, then antigenic evolution of the molecule cannot occur (Palese & Young, 1982) . In several instances it has not been possible to isolate virus variants that are resistant to neutralization by a monoclonal antibody (Nakajima & Kendal, 1981 ; Lefrancois & Lyles, 1983; Parrish & Carmichael, 1983; Coelingh et al., 1985 ; Jimenez et al., 1986 ), but it is not known whether this is because resistant variants would necessarily be inviable, or merely because they arise at a very low frequency. The emergence of antigenic variants will also be affected by the number of different epitopes that are targets for a neutralizing response, since if there are many such epitopes successful variants must contain several independent mutations and so will be extremely rare (Palese & Young, 1982; Jimenez et al., 1986) . Perhaps in these instances variation may be limited by the number of individuals affected (Palese & Young, 1982; Verhoeyen et al., 1983; Buonagurio et al., 1985) or the length of the virus replication cycle (Buonagurio et al., 1985) . Finally, the rate of variation of a virus may be affected by the extent to which it exists as a collection of related co-circulating strains. A virus such as coxsackievirus B4 with a high degree of strain variability (Prabhakar et al., 1982) may have a relatively low rate of variation for any particular strain because the prevalence of that strain is reduced in proportion to the number of co-circulating strains.
Together, these factors may determine the rate of field variation of a virus by either limiting or promoting the spread of variants in a population. Although the relatively high mutation rate of eukaryotic viruses is undoubtedly important in generating a pool of mutant genomes from which new variants can emerge, it may be that differences between viruses in their rate of variation reflect differences in selective forces rather than differences in the mutation rate. For example, the high rate of functionally silent nucleotide substitution in influenza virus (Hayashida et al., 1985) , and the extreme variation observed between strains of the acqu!red immune deficiency syndrome virus isolated from different individuals (references in Coffin, 1986) or from the same individual at different times (Hahn et al., 1986) may reflect the immunochemistry and epidemiology of these viruses rather than consequences of unusually high rates of mutation. 
